Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
BioCryst Pharmaceuticals, Inc. (NQ: BCRX)
8.700 USD  -0.500 (-5.43%)
Streaming Delayed Price  /  Updated: 1:13 PM EDT, Apr 23, 2014  /  Add to My Watchlist      
(BCRX) Community Analysis from
April 23, 2014
(Penny Stock DD, 12/4/10)
Date: 4 December 2010 (RTTNews) - BioCryst Pharmaceuticals, Inc. (BCRX) announced the presentation of new ...(read more)
(Stock Wizard, 9/16/10)
Shares of BioCryst Pharmaceuticals, Inc. (NasdaqGM: BCRX) surged as much as 3% after it announced today positive top-line results from its randomized, double-blind, multi-center,...(read more)
(, 2/4/10)
While select swine flu players have seen their pops and drops, BioCryst Pharmaceuticals (BCRX) may have emerged as the small-cap champion of the 2009 pandemic. Birmingham, Alabama-based biopharmaceutical small-cap BioCryst...(read more)
BioCryst Pharmaceuticals (BCRX) Company Overview

There is no analysis for BCRX yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here